Entrinsic Health Solutions is inextricably intertwined with the medical community. To make certain all research protocols and product development aligns with medical findings and meets with established research requirements, we formed an advisory board of scientific and medical experts and industry opinion leaders.
Jervoise Andreyev, MD, PhD
Dr Jervoise Andreyev studied medicine and qualified as a doctor from the Royal London Hospital and later completed a PhD in molecular biology from the Institute of Cancer Research. He is the first gastroenterologist appointed specifically to treat the side effects of cancer treatments. His small multidisciplinary clinical and research teams have worked hard to produce very clinically focused evidence which is now starting to change the understanding of GI consequences of cancer therapies.
Henry J. Binder, MD
Chairman of the Scientific Advisory Board, Yale School of Medicine, Advisory Board and Professor Emeritus of and Senior Research Scientist in Medicine (Digestive Diseases)
Daniel B. Dennison, PhD, Chief Technology Officer and Board Director.
Ph.D. in food science and 25 years senior leadership roles at The Coca-Cola Company, including Vice President and Director of Research and Development and Vice President and and Director of Scientific Affairs. Global thought leader in food safety, member of American Association of the Advancement of Science and the Institute of Food Technologies and founding member of the Centers for Disease Control Foundation.
Olivier Fontaine, MD, MS, FACP
Medical Officer for World Health Organization in the Diarrheal Diseases Control Programme. MD, University Paris V; MS in Molecular Biology, University Paris VI Jussieu.
Charles. F. Fuchs, MD, MPH
Chief of the Gastrointestinal Oncology Division, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School, and Robert T. and Judith B. Hale Chair in Pancreatic Cancer.